128 results
Page 5 of 7
6-K
EX-99.1
hz7khn
25 Aug 20
Mereo BioPharma Announces Initiation of Placebo-Controlled Phase 1b/2 Clinical Trial with Alvelestat in COVID-19 Respiratory Disease
11:14am
F-3
uyweu0q5p59 gw
6 Jul 20
Shelf registration (foreign)
4:58pm
POS AM
xftu2qein3kwfygwyq3z
2 Jul 20
Prospectus update (post-effective amendment)
3:57pm
6-K
EX-99.1
4oq2qqijeig vfokm777
30 Jun 20
Result of Annual General Meeting
4:07pm
6-K
EX-99.2
kr4nzot0yg0l2v9b5 2x
30 Jun 20
Result of Annual General Meeting
4:07pm
6-K
EX-99.3
ex9f40
30 Jun 20
Result of Annual General Meeting
4:07pm
6-K
inuojla86r3hs4opu9s
16 Jun 20
Current report (foreign)
4:13pm
6-K
EX-99.1
73j97rs 93cmw6pl79h
9 Jun 20
Publication of Circular and Notice of General Meeting
4:15pm
6-K
EX-99.1
5h6gc6rixe
5 Jun 20
Mereo BioPharma Announces Completion of $70 Million Private Placement
12:00am
6-K
EX-99.1
laafg hf4ph3qp01
27 May 20
Notice of Annual General Meeting
7:37am
6-K
EX-99.1
vxfh2fzd92qvqgbrh
22 May 20
Annual General Meeting
9:31am
6-K
EX-99.1
1eycbhsze96bw3wa0a
27 Mar 20
Business Update and Directorate Change
9:09am
F-1/A
1lv2kd fek5cj6969l
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
8sarrd 6eibgfkazkeog
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
6-K
EX-99.1
83vsac mr7vbf9c
28 Feb 20
Current report (foreign)
9:46am
6-K
EX-99.1
ze64 oz2h2bkazogd1
19 Feb 20
Mereo BioPharma Announces Equity Investment of $3 Million from New U.S. Institutional Investor
9:32am
F-1
8fd0 0xo5vhxap
18 Feb 20
Registration statement (foreign)
5:15pm
6-K
EX-99.1
o2htke
12 Feb 20
Mereo Biopharma Announces Update on Distribution Related to Contingent Value Rights Following Recent Oncologie Licensing Agreement for Navicixizumab
9:48am
6-K
EX-99.1
ewwln6vss 5r2j
10 Feb 20
Current report (foreign)
7:20am